Akut limfoid leukémia (ALL): vizsgálatok itt: Kína
169 trials · From ClinicalTrials.gov, checked 2026. november 16.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleBlinatumomab Plus Venetoclax Sequenced With Inotuzumab Ozogamicin in Treating B-ALL
- Where
- Hangzhou
- Életkor
- 40 év and over
- People
- 20
- Run by
- First Affiliated Hospital of Zhejiang University
See details and how to joinNCT06554626 - 1. fázisTaking peopleCD19/CD22 CAR-T Cells in Adults With R/R ALL or NHL
- Where
- Nanchang, Shanghai
- Életkor
- 18 év and over
- People
- 48
- Run by
- Rong Tao
See details and how to joinNCT06445803 - 4. fázisTaking peopleBelimumab After Rituximab in Resistant Primary Juvenile SS
- Where
- Beijing
- Életkor
- 5 év to 18 év
- People
- 15
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT06410833 - Korai 1. fázisTaking peopleCD19-BAFF CAR-T Cells Therapy for Patients With Relapsed / Refractory B-cell ALL and B-cell NHL
- Where
- Hangzhou
- Életkor
- 18 év and over
- People
- 20
- Run by
- Zhejiang University
See details and how to joinNCT06346912 - 3. fázisTaking peopleHaplo-cord HCT vs. Haplo-HCT for T-ALL Patients
- Where
- Suzhou
- People
- 146
- Run by
- The First Affiliated Hospital of Soochow University
See details and how to joinNCT06381817 - 1/2. fázisTaking peopleTGRX-814 Chinese Phase I/II in Patients With Hematological Malignancies
- Where
- Tianjin
- Életkor
- 18 év and over
- People
- 30
- Run by
- Shenzhen TargetRx Co., Ltd.
See details and how to joinNCT06206174 - No phaseTaking peopleCD19-targeted CAR T Cell Autotransfusion for the Treatment of Recurrent/Refractory B-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma in Children With CD19+
- Where
- Tianjin
- Életkor
- 3 év to 18 év
- People
- 60
- Run by
- Zhu Xiaofan
See details and how to joinNCT06355739 - 2. fázisTaking peopleRDC-Blinatumomab Versus hyperCVAD for Ph-negative B-ALL.
- Where
- Suzhou
- Életkor
- 15 év to 65 év
- People
- 124
- Run by
- Chen Suning
See details and how to joinNCT06250959 - 4. fázisTaking peopleBlinatumomab for Relapsed Acute B Lymphoblastic Leukemia After Transplantation
- Where
- Zhenzhou
- Életkor
- Up to 65 év
- People
- 60
- Run by
- Suping ZHANG
See details and how to joinNCT06339775 - 2. fázisTaking peopleA Single-arm, Open-label Study of Olverembatinib, CD3/CD19 Bispecific T-cell Engager, and Chidamide in Patients With Newly Diagnosed Ph+ALL
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 67
- Run by
- Nanfang Hospital, Southern Medical University
See details and how to joinNCT06220487 - 1. fázisTaking peopleCD7 CAR-T in Adults With Relapsed or Refractory T-LBL/ALL Clinical Study
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 9
- Run by
- Hebei Senlang Biotechnology Inc., Ltd.
See details and how to joinNCT06136364 - 2. fázisTaking peopleCD19/CD22 Bispecific CAR-T Cell Therapy for Relapsed/Refractory B-cell Lymphoma or Acute Lymphoblastic Leukemia
- Where
- Beijing
- Életkor
- 14 év to 85 év
- People
- 100
- Run by
- Beijing Tongren Hospital
See details and how to joinNCT06081478 - 2. fázisNot yet taking people in KínaA Study of Olverembatinib Combined With Blinatumomab in the Treatment of Ph+ ALL
- Where
- Suzhou
- Életkor
- 18 év to 100 év
- People
- 22
- Run by
- The First Affiliated Hospital of Soochow University
See details and how to joinNCT05931757 - 4. fázisTaking peopleSouth China Children Cancer Group - Relapsed-Acute Lymphoblastic Leukemia 2022 Protocol
- Where
- Guangzhou
- Életkor
- 1 év to 14 év
- People
- 210
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT05682131 - No phaseTaking peopleClinical Study of Senl-T7 CAR T Cells in the Treatment of Relapsed and Refractory CD7+ Acute T-ALL/T-LBL
- Where
- Beijingcun
- Életkor
- 2 év to 70 év
- People
- 100
- Run by
- Hebei Senlang Biotechnology Inc., Ltd.
See details and how to joinNCT05626400 - No phaseTaking peopleCD7 CAR-T Cells in T-cell Lymphoma/Leukemia
- Where
- Shenzhen
- Életkor
- 18 év to 75 év
- People
- 20
- Run by
- Shenzhen University General Hospital
See details and how to joinNCT05620680 - Korai 1. fázisTaking peopleA Study of CTA101 UCAR-T Cell Injection in Patients With Relapsed or Refractory CD19+ B-line Hematological Malignancy
- Where
- Hangzhou
- Életkor
- 3 év to 70 év
- People
- 72
- Run by
- He Huang
See details and how to joinNCT04227015 - Korai 1. fázisNot yet taking people in KínaCD79b CAR-T Cell Therapy for Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia and B-cell Non-Hodgkin's Lymphoma
- Where
- Hangzhou
- People
- 72
- Run by
- Zhejiang University
See details and how to joinNCT04609241 - No phaseTaking peopleDesign and Implementation of the Pediatric Liver Transplantation Biobank
- Where
- Chongqing
- Életkor
- 1 hónap to 18 év
- People
- 500
- Run by
- Children's Hospital of Chongqing Medical University
See details and how to joinNCT04477967